Results 241 to 250 of about 11,906,519 (291)

Versatile Microgel Platform for Intervertebral Disc Degeneration Therapy: Targeting Pericyte‐Mediated Fibrosis and Protecting Nucleus Pulposus Cells

Advanced Science, EarlyView.
The engineered MMS@TRP microgel enables targeted, acid‐responsive delivery of a miR‐21 inhibitor to pericytes. It effectively suppresses disc fibrosis by inhibiting TGF‐β signaling while protecting nucleus pulposus cells via sustained, antioxidant tannic acid release.
Fei Ma, Zhen Zhao, Chuan Guo, Yuheng Liu, Yu Wang, Dengbo Yao, Weiqiang Lan, Dejun Zhong, Chen Fan, Yao He, Mei Zhang, Qingquan Kong, Yunfeng Lin   +12 more
wiley   +1 more source

The impact of anti-vascular endothelial growth factor therapy on the activation status of retinal macrophages/microglia in patients with diabetic retinopathy and familial exudative vitreoretinopathy and its association with treatment response. [PDF]

Am J Transl Res
Li J, Fei P, Zhang X, Rao Y, Li J, Zhao P.   +5 more
europepmc   +1 more source

Low‐Intensity Ultrasound‐Triggered Microbubble Cavitation Attenuates Diabetic Kidney Injury Partially by Reversing Endothelial Dysfunction

Advanced Science, EarlyView.
Non‐invasive low‐intensity pulsed ultrasound ‐triggered cavitation of clinically approved diagnostic‐grade microbubbles delivers favorable mechanical stimuli to renal microvasculature. This intervention restores renal microvascular homeostasis, alleviates DKD‐associated histological and functional damage, and suppresses inflammatory and fibrotic ...
Yubo Lai, Liang Zhang, Wenxin Tao, Jieyuan An, Lantian Wang, Zhaoyou Liu, Guodong Yang, Pengying Wu, Lijun Yuan   +8 more
wiley   +1 more source

Intravitreal anti-vascular endothelial growth factor agents as an adjunct for proliferative diabetic retinopathy: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Song X, Li L, Wang X, Zhang X, Lei Q, Liu G, Wang L, Chen J.   +7 more
europepmc   +1 more source

Combined Treatment of Hyperbaric Oxygen and Anti-vascular Endothelial Growth Factor Therapy in Cilioretinal Artery Occlusion Associated With Central Retinal Vein Occlusion. [PDF]

Cureus
Brissos J, Pinto R, Frazão S, Nogueira V.   +3 more
europepmc   +1 more source

Simultaneous bilateral intravitreal anti-vascular endothelial growth factor injections from one vial for diabetic macular edema: a retrospective analysis. [PDF]

Front Med (Lausanne)
Dai Y, Lou J, Wen J, Liang G, Xu J, Jing Z, Wang J.   +6 more
europepmc   +1 more source

The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America. [PDF]

Ophthalmol Ther
Tabano D, Watane A, Gale R, Cox O, Hill SR, Longworth L, Oluboyede Y, Ahmed A, Patel NA.   +8 more
europepmc   +1 more source

Evaluation of Intraocular Anti-vascular Endothelial Growth Factor (VEGF) Drug-Associated Adverse Events Using Spontaneous Reporting Databases. [PDF]

Cureus
Sato M, Kageyama K, Ito S, Ino Y, Bunchuailua W, Rungpragayphan S, Yamazaki T, Sugishita K, Krichanchai S, Nakao S, Sriamornsak P, Takeuchi H, Nakamura M.   +12 more
europepmc   +1 more source

Characteristics of patients lost to follow-up after intravitreal anti-vascular endothelial growth factor therapy for exudative age-related macular degeneration. [PDF]

BMC Ophthalmol
Cho Y, Yoo WS, Kim SJ, Chung I.
europepmc   +1 more source

Comparative Real-World Efficacy of Anti-Vascular Endothelial Growth Factor Agents in Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Study.

Ophthalmologica
Berco E, Kozlov Y, Ostrovsky M, Tuli R, Kin Man Lee T, Samocha K, Shcolnik E, Goldfeather Ben Zaken S, Shoham-Hazon N.   +8 more
europepmc   +1 more source